Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Hydroxycinnamic Acids, COPII, and cGAS–STING
2026-08-15
The reference study identifies the Sec24 B-site of the COPII coat complex as a molecular target of cinnamic, caffeic, and ferulic acids, linking cargo sorting to inflammatory STING signaling. Structural, cellular, and diabetic mouse experiments suggest that blocking STING trafficking from the endoplasmic reticulum to the Golgi can reduce steatosis, improve metabolic control, and limit hepatic injury.
-
ECL Chemiluminescent Substrate Detection Kit Workflow
2026-08-14
Improve low-abundance protein immunoblotting with a hypersensitive HRP substrate, longer signal persistence, and practical exposure controls. This workflow connects ferroptosis-focused retinal research with reproducible western blot chemiluminescent detection on nitrocellulose or PVDF membranes.
-
Bortezomib and the MAPK10–KRT16 Axis
2026-08-14
Bortezomib (PS-341) offers a powerful way to interrogate how proteasomal turnover shapes apoptosis, protein stability, and metastatic behavior. This article develops a turnover-aware assay strategy linking 20S proteasome inhibition with the MAPK10–KRT16–RNF213 pathway in NSCLC research.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-08-13
This study identifies striatal dopamine D2 receptor-expressing medium spiny neurons as a cellular substrate linking Neuroligin 1 loss to autistic-like repetitive behaviors. By combining cell-specific manipulation, behavioral analysis, single-nucleus RNA sequencing, and protein validation, the authors implicate D2-MSN hyperactivation and PKC overactivation in excessive self-grooming and digging.
-
Maternal Surgery, Calpain, and Offspring Cognition
2026-08-13
The reference study identifies excessive calpain activation as a mechanistic link between maternal non-obstetric surgery during pregnancy and later offspring cognitive impairment. In a pregnant Sprague–Dawley rat model, postnatal MDL 28170 or TrkB activation partially rescued hippocampal synaptic abnormalities and behavioral deficits, implicating disrupted BDNF/TrkB signaling in the phenotype.
-
Decitabine Priming Expands Progenitor Tex Under Anti–PD-1
2026-08-12
The reference study shows that low-dose decitabine can improve anti–PD-1 efficacy by expanding and sustaining proliferative CD8+ progenitor exhausted T cells rather than merely activating terminally exhausted populations. Its integrated tumor, transcriptional, epigenetic, and mechanistic analyses identify sustained JunD/AP-1 activity as a potential explanation for improved T cell persistence and tumor control.
-
Bafilomycin C1 in High-Content Cell Assays
2026-08-12
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that links lysosomal acidification to interpretable phenotypic screening. This guide shows how to use its mechanism as a deliberate assay control alongside deep-learning analysis, autophagy measurements, and cardiomyocyte safety workflows.
-
Indole-3-pyruvic acid: Bench Workflows
2026-08-11
Indole-3-pyruvic acid connects mechanistic plant auxin studies with carefully controlled immune-cell assays. This practical guide covers TAA1 feedback experiments, fresh-solution handling, PBMC dose planning, and troubleshooting across plant, fungal, and mammalian workflows.
-
10 mM dNTP Mixture: Assay Design for LNP DNA Studies
2026-08-11
Learn how a 10 mM dNTP mixture can strengthen DNA amplification, sequencing, and control design in lipid nanoparticle studies. This article connects reproducible nucleotide handling with mechanistic lessons from research on cholesterol-dependent intracellular trafficking.
-
EGCG Nanoparticles Enhance FLASH-RT Antitumor Effects
2026-08-10
Xu et al. report that functionalized, self-assembled epigallocatechin gallate nanoparticles enhance FLASH-RT by increasing radiation-associated oxidative stress and tumor-cell DNA damage while promoting antitumor immune responses. The study provides a preclinical framework for combining nanomedicine, ultra-high-dose-rate radiotherapy, and immune profiling, although clinical transferability remains unresolved.
-
Bifendate (DDB): From Omics to Assay Design
2026-08-09
Bifendate (DDB) is more than a conventional hepatoprotection agent: its value lies in connecting liver-injury phenotypes with multiomics-defined regulatory modules. This guide translates those findings into better assay selection, dosing logic, and interpretation.
-
From Field Images to Molecular Validation
2026-08-08
Deep-learning image analysis can accelerate sweetpotato virus disease screening, but translational programs still need an orthogonal molecular layer. This article explains how endpoint PCR, TA-cloning compatibility, and direct gel loading can turn field observations into reproducible validation workflows.
-
2X Taq PCR Master Mix for Plant Virus Workflows
2026-08-07
Use a streamlined Taq workflow to move from plant-sample genotyping and cloning to gel-ready amplicon analysis, while recognizing that image-based disease screening and molecular confirmation answer different questions. The dye-containing formulation reduces pipetting steps, and its adenine-overhang chemistry supports practical TA-cloning workflows.
-
VE-821: ATR Kinase Inhibition Unveils New Horizons in DDR an
2026-08-07
Discover how VE-821, a potent ATR kinase inhibitor, is redefining DNA damage response research and unlocking novel insights into viral epigenetic regulation. This in-depth analysis explores the compound’s unique mechanistic advantages, advanced protocol guidance, and implications for cross-domain studies.
-
Jiedu Xiaozheng Yin Drives M1 Macrophage Shift in Colitis-CR
2026-08-06
Liu et al. provide mechanistic evidence that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer by promoting M1 macrophage polarization via the TLR4 pathway. These findings clarify immune microenvironment modulation as a strategy for tumor suppression and offer a framework for dissecting transcriptional regulation in cancer models.